$14.60
0.302.10%
In chiusura: -
$14.60
0.000.00%
After hour: 4:28 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Edgewise Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Edgewise Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Edgewise Therapeutics Inc addetti ai lavori?
A Edgewise Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di - azioni del valore di -, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Edgewise Therapeutics Inc
Numero di azioni emesse
105.346M
Azioni possedute dagli insider
223.063K
Percentuale posseduta dagli Insider
0.21%
Azioni possedute dagli investitori istituzionali
32.433M
Percentuale posseduta dagli investitori istituzionali
30.8%
Aug 14, 2025 | GENERAL COUNSEL | 3.68K | $13.39 | -$28.10K | SELL-OPTIONS | 56.39% | 10.21K | Aug 12 | ||
Aug 14, 2025 | CHIEF BUSINESS OFFICER | 3.29K | $13.39 | -$33.36K | SELL-OPTIONS | 16.16% | 23.64K | Aug 12 | ||
Aug 14, 2025 | CHIEF FINANCIAL OFFICER | 4.35K | $13.39 | -$19.12K | SELL-OPTIONS | 5.32% | 86.16K | Aug 12 | ||
Aug 14, 2025 | CHIEF SCIENTIFIC OFFICER | 3.87K | $13.39 | -$25.54K | SELL-OPTIONS | 19.84% | 23.40K | Aug 12 | ||
Aug 14, 2025 | PRESIDENT AND CEO | 10.00K | $13.39 | -$106.76K | SELL-OPTIONS | 21.25% | 57.02K | Aug 12 | ||
Aug 14, 2025 | CMO | 2.92K | $13.39 | -$38.33K | SELL-OPTIONS | 13.01% | 25.36K | Aug 12 | ||
May 07, 2025 | CHIEF SCIENTIFIC OFFICER | 3.66K | $16.45 | -$25.52K | SELL-OPTIONS | 24.61% | 18.52K | May 01 - May 02 | ||
May 07, 2025 | GENERAL COUNSEL | 3.28K | $16.45 | -$31.76K | SELL-OPTIONS | 100.83% | 6.53K | May 01 - May 02 | ||
May 07, 2025 | PRESIDENT AND CEO | 6.14K | $16.45 | -$70.36K | SELL-OPTIONS | 15.02% | 47.03K | May 01 - May 02 | ||
May 07, 2025 | CMO | 5.23K | $16.45 | -$85.35K | SELL-OPTIONS | 31.97% | 21.59K | May 01 - May 02 | ||
May 07, 2025 | CHIEF BUSINESS OFFICER | 3.52K | $16.45 | -$27.82K | SELL-OPTIONS | 20.89% | 20.36K | May 01 - May 02 | ||
May 07, 2025 | CHIEF FINANCIAL OFFICER | 3.90K | $16.45 | -$21.62K | SELL-OPTIONS | 5.05% | 81.01K | May 01 - May 02 | ||
Apr 04, 2025 | DIRECTOR | 496.77K | $20.13 | $10.00M | BUY | ∞ | 443.79K | Apr 03 | ||
Apr 04, 2025 | DIRECTOR | 496.77K | $20.13 | $10.00M | BUY | ∞ | 443.79K | Apr 03 | ||
Mar 11, 2025 | CHIEF SCIENTIFIC OFFICER | 0.00 | $15.10 | -$5.97K | SELL-OPTIONS | 0.00% | 14.86K | Mar 07 | ||
Mar 11, 2025 | PRESIDENT AND CEO | 0.00 | $15.09 | -$2.98K | SELL-OPTIONS | 0.00% | 40.89K | Mar 07 | ||
Feb 07, 2025 | CHIEF SCIENTIFIC OFFICER | 0.00 | $15.11 | -$275.12K | SELL-OPTIONS | 0.00% | 14.86K | Feb 05 - Feb 06 | ||
Feb 07, 2025 | PRESIDENT AND CEO | 0.00 | $15.76 | -$273.96K | SELL-OPTIONS | 0.00% | 40.89K | Feb 05 - Feb 06 | ||
Feb 07, 2025 | CHIEF BUSINESS OFFICER | 0.00 | $15.98 | -$281.00K | SELL-OPTIONS | 0.00% | 16.84K | Feb 05 | ||
Jan 30, 2025 | CMO | 0.00 | $17.35 | -$513.66K | SELL-OPTIONS | 0.00% | 16.36K | Jan 28 | ||
Dec 31, 2024 | CHIEF SCIENTIFIC OFFICER | 0.00 | $13.78 | -$2.72M | SELL-OPTIONS | 0.00% | 14.86K | Dec 30 | ||
Dec 27, 2024 | CHIEF DEVELOPMENT OFFICER | 0.00 | $19.31 | -$616.32K | SELL-OPTIONS | 0.00% | 6.72K | Dec 24 | ||
Sep 24, 2024 | CHIEF SCIENTIFIC OFFICER | 0.00 | $14.22 | -$2.11M | SELL-OPTIONS | 0.00% | 12.72K | Sep 20 | ||
Sep 24, 2024 | GENERAL COUNSEL | 0.00 | $14.43 | -$1.95M | SELL-OPTIONS | 0.00% | 3.25K | Sep 20 - Sep 23 | ||
Sep 24, 2024 | CMO | -7.16K | $28.29 | -$202.60K | SELL | -33.00% | 14.54K | Sep 20 | ||
Sep 24, 2024 | CHIEF BUSINESS OFFICER | 0.00 | $15.48 | -$1.14M | SELL-OPTIONS | 0.00% | 15.12K | Sep 20 | ||
Sep 24, 2024 | CHIEF FINANCIAL OFFICER | -29.02K | $15.25 | -$3.39M | SELL | -80.78% | 6.90K | Sep 20 | ||
May 03, 2024 | GENERAL COUNSEL | 3.25K | $18.91 | -$36.99K | SELL-OPTIONS | ∞ | 3.25K | May 01 - May 02 | ||
May 03, 2024 | CHIEF FINANCIAL OFFICER | 3.05K | $18.91 | -$40.79K | SELL-OPTIONS | 9.48% | 35.23K | May 01 - May 02 | ||
May 03, 2024 | CHIEF BUSINESS OFFICER | 3.49K | $18.91 | -$32.49K | SELL-OPTIONS | 35.14% | 13.42K | May 01 - May 02 | ||
May 03, 2024 | CHIEF SCIENTIFIC OFFICER | 3.63K | $18.91 | -$29.80K | SELL-OPTIONS | 100.72% | 7.24K | May 01 - May 02 | ||
May 03, 2024 | CMO | 6.74K | $18.91 | -$69.63K | SELL-OPTIONS | 51.17% | 19.90K | May 01 - May 02 | ||
May 03, 2024 | PRESIDENT AND CEO | 7.26K | $18.91 | -$59.60K | SELL-OPTIONS | 21.61% | 40.89K | May 01 - May 02 | ||
Feb 09, 2024 | GENERAL COUNSEL | 0.00 | $10.97 | -$539.22K | SELL-OPTIONS | 0.00% | 0.00 | Feb 07 - Feb 09 | ||
Feb 09, 2024 | CHIEF BUSINESS OFFICER | 0.00 | $10.98 | -$180.96K | SELL-OPTIONS | 0.00% | 7.02K | Feb 07 - Feb 09 | ||
Jan 25, 2024 | CHIEF FINANCIAL OFFICER | 0.00 | $8.85 | -$1.25M | SELL-OPTIONS | 0.00% | 29.02K | Jan 23 | ||
Jan 25, 2024 | DIRECTOR | 454.55K | $11.00 | $5.00M | BUY | 3.18% | 14.76M | Jan 23 | ||
Jan 25, 2024 | DIRECTOR | 454.55K | $11.00 | $5.00M | BUY | 3.18% | 14.76M | Jan 23 | ||
Dec 28, 2023 | — | 10.86K | $9.30 | $100.96K | BUY | ∞ | 10.86K | Dec 26 | ||
Dec 28, 2023 | GENERAL COUNSEL | -8.50K | $10.50 | -$89.22K | SELL | -100.00% | 0.00 | Dec 27 | ||
Dec 28, 2023 | CHIEF SCIENTIFIC OFFICER | -172.59K | $9.33 | -$1.61M | SELL | -97.95% | 3.61K | Dec 26 | ||
May 03, 2023 | CHIEF BUSINESS OFFICER | 3.46K | $8.90 | -$15.56K | SELL-OPTIONS | 97.25% | 7.02K | May 01 - May 02 | ||
May 03, 2023 | GENERAL COUNSEL | 3.31K | $8.90 | -$16.89K | SELL-OPTIONS | 101.75% | 6.57K | May 01 - May 02 | ||
May 03, 2023 | CHIEF FINANCIAL OFFICER | 3.87K | $8.90 | -$11.90K | SELL-OPTIONS | 31.60% | 16.13K | May 01 - May 02 | ||
May 03, 2023 | CHIEF SCIENTIFIC OFFICER | 3.61K | $8.90 | -$14.27K | SELL-OPTIONS | 2.09% | 176.19K | May 01 - May 02 | ||
May 03, 2023 | CMO | 7.16K | $8.90 | -$28.98K | SELL-OPTIONS | 255.97% | 9.96K | May 01 - May 02 | ||
May 03, 2023 | PRESIDENT AND CEO | 7.21K | $8.90 | -$28.52K | SELL-OPTIONS | 27.31% | 33.62K | May 01 - May 02 | ||
Oct 05, 2022 | GENERAL COUNSEL | 0.00 | $5.84 | -$37.03K | SELL-OPTIONS | 0.00% | 3.00K | Oct 03 | ||
Sep 16, 2022 | DIRECTOR | 484.50K | $10.32 | $5.00M | BUY | 3.51% | 14.30M | Sep 16 | ||
Sep 16, 2022 | DIRECTOR | 484.50K | $10.32 | $5.00M | BUY | 3.51% | 14.30M | Sep 16 | ||
Sep 16, 2022 | 10% OWNER | 484.50K | $10.32 | $5.00M | BUY | 8.67% | 6.07M | Sep 14 | ||
Sep 08, 2022 | GENERAL COUNSEL | 0.00 | $6.42 | -$42.47K | SELL-OPTIONS | 0.00% | 3.00K | Sep 06 | ||
Aug 05, 2022 | GENERAL COUNSEL | 0.00 | $5.32 | -$73.60K | SELL-OPTIONS | 0.00% | 3.00K | Aug 03 | ||
Jul 07, 2022 | GENERAL COUNSEL | 0.00 | $4.85 | -$64.93K | SELL-OPTIONS | 0.00% | 3.00K | Jul 05 - Jul 06 | ||
Jun 21, 2022 | GENERAL COUNSEL | 0.00 | $4.26 | -$349.32K | SELL-OPTIONS | 0.00% | 3.00K | Jun 16 - Jun 21 | ||
Jun 15, 2022 | GENERAL COUNSEL | 0.00 | $3.41 | -$141.01K | SELL-OPTIONS | 0.00% | 3.00K | Jun 13 - Jun 15 | ||
Jun 10, 2022 | GENERAL COUNSEL | 0.00 | $3.58 | -$156.49K | SELL-OPTIONS | 0.00% | 3.00K | Jun 08 - Jun 10 | ||
Jun 07, 2022 | GENERAL COUNSEL | 0.00 | $3.87 | -$225.64K | SELL-OPTIONS | 0.00% | 3.00K | Jun 03 - Jun 07 | ||
May 20, 2022 | DIRECTOR | 138.00K | $7.21 | $994.98K | BUY | 1.01% | 13.82M | May 18 | ||
May 20, 2022 | DIRECTOR | 138.00K | $7.21 | $994.98K | BUY | 1.01% | 13.82M | May 18 | ||
May 18, 2022 | GENERAL COUNSEL | -10.80K | $7.42 | -$80.15K | SELL | -78.26% | 3.00K | May 16 | ||
Nov 17, 2021 | CHIEF SCIENTIFIC OFFICER | -479.00 | $19.11 | -$9.16K | SELL | -100.00% | 0.00 | Nov 15 | ||
Nov 12, 2021 | CHIEF SCIENTIFIC OFFICER | -69.74K | $19.91 | -$1.39M | SELL | -99.32% | 479.00 | Nov 09 - Nov 12 | ||
Nov 08, 2021 | CHIEF SCIENTIFIC OFFICER | -29.45K | $19.82 | -$583.82K | SELL | -29.55% | 70.22K | Nov 04 - Nov 08 | ||
Nov 03, 2021 | CHIEF SCIENTIFIC OFFICER | -44.17K | $17.88 | -$789.91K | SELL | -30.71% | 99.67K | Nov 01 - Nov 03 | ||
Oct 18, 2021 | CHIEF SCIENTIFIC OFFICER | -7.18K | $18.17 | -$130.48K | SELL | -4.76% | 143.84K | Oct 14 - Oct 15 | ||
Oct 13, 2021 | CHIEF SCIENTIFIC OFFICER | -1.27K | $18.02 | -$22.89K | SELL | -0.83% | 151.02K | Oct 11 | ||
Oct 08, 2021 | CHIEF SCIENTIFIC OFFICER | -21.03K | $18.39 | -$386.74K | SELL | -12.13% | 152.29K | Oct 06 - Oct 08 | ||
Oct 05, 2021 | CHIEF SCIENTIFIC OFFICER | -5.78K | $18.24 | -$105.41K | SELL | -3.23% | 173.32K | Oct 01 - Oct 05 | ||
Sep 30, 2021 | CHIEF SCIENTIFIC OFFICER | -26.45K | $17.10 | -$452.48K | SELL | -12.87% | 179.10K | Sep 28 - Sep 29 | ||
Sep 27, 2021 | CHIEF SCIENTIFIC OFFICER | -58.55K | $18.30 | -$1.07M | SELL | -22.17% | 205.55K | Sep 23 - Sep 27 | ||
Mar 31, 2021 | DIRECTOR | 3.49M | $16.00 | $250.00K | BUY | ∞ | 15.63K | Mar 30 | ||
Mar 31, 2021 | DIRECTOR | 13.36M | $16.00 | $5.75M | BUY | ∞ | 13.36M | Mar 30 | ||
Mar 31, 2021 | DIRECTOR | 13.36M | $16.00 | $5.75M | BUY | ∞ | 13.36M | Mar 30 | ||
Mar 31, 2021 | 10% OWNER | 5.59M | $16.00 | $10.00M | BUY | ∞ | 5.59M | Mar 30 | ||
Mar 30, 2021 | 10% OWNER | 3.93M | $16.00 | $10.00M | BUY | ∞ | 3.93M | Mar 30 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.